Renal Patient and Donor Foundation

What Renal Patient and Donor Foundation does

The Renal Patient and Donor Foundation, operating as the Kidney Patient and Donor Alliance Canada, is a Canadian not-for-profit patient advocacy organization founded in July 2022 from a Patient Partner Workshop of transplant recipients and living kidney donors. It serves kidney patients (chronic kidney disease and end-stage kidney disease), living kidney donors, family members and caregivers, and engages healthcare professionals and researchers. Its core offerings are the Patient Partner Coalition (a grassroots advocacy group), the Transplant Ambassador Program (a patient-led peer support program embedded in hospitals, developed in 2017 by partner volunteers), and the Transplant 1st Campaign, which calls for system-wide reform to make kidney transplant the first and best treatment for kidney failure. Underlying infrastructure is non-technological — research-based advocacy, knowledge translation, and coalition mobilization — rather than a software platform.

The organization generates no product revenue. Operating funds come from donations and corporate sponsorship by pharmaceutical companies (Lilly Canada, AstraZeneca Canada, Astellas Pharma Canada, Takeda Canada, Paladin Pharma) and partner organizations such as endpkd.ca and Can-SOLVE CKD (the latter funded in part by the Canadian Institutes of Health Research). All programs and member participation are free. Distribution is purely digital and advocacy-based: a WordPress website (kidneyalliance.ca), email newsletter, Facebook/Instagram/LinkedIn presence, earned media placements on CBC podcasts, and in-person advocacy events such as Kidney Advocacy Day at Queens Park. Strategic research partners include Can-SOLVE CKD, ICES (Institute for Clinical Evaluative Sciences) via its Kidney, Dialysis and Transplantation Program, and the Ontario Renal Network.

Membership and governance are patient- and donor-led. Susan McKenzie serves as President and is a kidney transplant recipient and co-author of 13 peer-reviewed papers as a patient partner since 2017. The board and advisory council comprise transplant recipients, living donors, and senior figures from nephrology research (e.g., Dr. Amit Garg, Dr. Kyla Naylor), pharmaceutical leadership (e.g., former Astellas Canada President Michael Tremblay), and Canadian healthcare policy. With 1-10 staff and a national rather than provincial operating footprint, the Alliance functions as a lean advocacy operator whose principal competitive asset is credentialed lived experience applied to healthcare-system reform.

Name

Renal Patient and Donor Foundation

Legal name

Kidney Patient and Donor Alliance Canada

Website

https://kidneyalliance.ca

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

The Renal Patient and Donor Foundation (operating as the Kidney Patient and Donor Alliance Canada) is a Canadian not-for-profit, founded July 2022, that mobilizes kidney patients, living donors, and families to advocate for transplant-first healthcare reform through the Patient Partner Coalition, Transplant Ambassador Program, and Transplant 1st Campaign.

Ownership category

akta.pro rank

Product category

Healthcare Patient Advocacy

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Social Services (8300), Services-Health Services (8000)

akta.pro primary industry

Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB)

Keywords

• Patient advocacy
• Kidney transplant
• Living donor support
• Healthcare reform
• Peer support programs

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Support: The organization receives financial support from pharmaceutical companies and other healthcare industry partners. The website indicates they are grateful for support from generous supporters including pharmaceutical companies (Lilly, AstraZeneca, Astellas, Takeda, Paladin-Pharma) and organizations like endpkd.ca.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

The Renal Patient and Donor Foundation (operating as Kidney Patient and Donor Alliance Canada) is a not-for-profit patient advocacy organization that mobilizes kidney patients, living kidney donors, and their families to advocate for system-wide healthcare reform that prioritizes kidney transplant over dialysis. It delivers peer support through its Transplant Ambassador Program (TAP) — a hospital-embedded patient-led program — and runs the Transplant 1st Campaign and Patient Partner Coalition to push for policy change, disseminate best-practice research, and connect Canadians affected by kidney disease with resources and advocacy opportunities.

Product overview

The Renal Patient and Donor Foundation (operating as Kidney Patient and Donor Alliance Canada) is a not-for-profit patient advocacy organization, not a technology product company. The organization provides advocacy services, a patient partner coalition (Transplant 1st Campaign), the Transplant Ambassador Program (a peer support program), and research resources for kidney patients and donors. The organization does not offer technology products, platforms, or software services.

Differentiator

Problem solved

Functional benefit

Brands

• Transplant 1st Campaign: The Alliance's first advocacy campaign calling for radical system-wide reform of the Canadian healthcare system to prioritize kidney transplant as the best treatment for kidney failure.
• Patient Partner Coalition (PPC)
• Transplant Ambassador Program (TAP)

Products and services

• Transplant Ambassador Program (TAP) A patient-led peer support program embedded within hospitals that provides kidney patients, their families, and potential kidney donors with regular opportunities to see and hear from people who have had successful transplant experiences. Designed for kidney patients, living donors, and their families in Canada.
• Transplant 1st Campaign Advocacy campaign calling for radical system-wide reform of the Canadian healthcare system to prioritize kidney transplant as the first and best treatment for kidney failure. Targeted at policymakers, healthcare administrators, and the broader Canadian kidney-care community.
• Patient Partner Coalition (PPC) A grassroots coalition of dialysis patients, kidney transplant recipients, and living kidney donors working in partnership with researchers and healthcare providers to advocate for transplant reform and translate research into system-wide change in Canada.

Quantifiable outcome

• Every 1% increase in transplant rate (from 5% to 6%) could result in 288 additional transplants per year and 1,440 lives saved over five years
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered core and minor.

• Transplant Ambassador Program (TAP)coreStrategic or Co-development PartnerThe Transplant Ambassador Program is a patient-led peer support program embedded within hospitals that provides kidney patients, their families, and potential kidney donors with opportunities to connect with successful transplant recipients. The Alliance partners with TAP to advance shared advocacy goals.
• Can-SOLVE CKDcoreStrategic or Co-development PartnerCan-SOLVE CKD is Canada's national kidney research initiative supporting patient-oriented research. The Patient Partner Coalition advances research projects including 'Mobilizing Research Findings to Achieve More Living Donor Kidney Transplants.' Can-SOLVE CKD is funded in part by the Canadian Institutes of Health Research through Canada's Strategy for Patient-Oriented Research (SPOR).
• Lilly CanadaminorOthersPharmaceutical company listed as a supporter of the Kidney Patient and Donor Alliance Canada.
• AstraZeneca CanadaminorOthersPharmaceutical company listed as a supporter of the Kidney Patient and Donor Alliance Canada.
• Astellas Pharma CanadaminorOthersPharmaceutical company listed as a supporter of the Kidney Patient and Donor Alliance Canada.
• Takeda CanadaminorOthersPharmaceutical company listed as a supporter of the Kidney Patient and Donor Alliance Canada.
• Paladin PharmaminorOthersPharmaceutical company listed as a supporter of the Kidney Patient and Donor Alliance Canada.
• endpkd.caminorOthersOrganization supporting patients with polycystic kidney disease listed as a supporter of the Kidney Patient and Donor Alliance Canada.
• Ontario Renal NetworkcoreStrategic or Co-development PartnerThe Transplant Ambassador Program, a key pillar of the Ontario Renal Network's Enhancing Access to Kidney Transplant and Living Donation Research Strategy, connects the Alliance with provincial healthcare system stakeholders.
• ICES (Institute for Clinical Evaluative Sciences)coreStrategic or Co-development PartnerICES provides research support including the Kidney, Dialysis and Transplantation Program. Dr. Kyla Naylor serves as adjunct scientist at ICES and supports coalition research initiatives.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• American Kidney Fund: U.S. nonprofit providing direct financial assistance to kidney patients and advocating for living donation and transplant access. Closely comparable patient-assistance-plus-advocacy model.
• Cystic Fibrosis Canada: Canadian patient advocacy charity for chronic disease with comparable model of patient-led research partnerships and policy advocacy for a specific disease population. Useful analog for chronic-disease advocacy strategy.
• Kidney Foundation of Canada: Canada's largest kidney-focused charity, funding kidney research, patient services, and advocacy. Directly comparable as a national kidney patient and donor advocacy organization in the same Canadian market.
• National Kidney Foundation: Premier U.S. kidney patient advocacy and research organization with analogous mission to drive kidney disease awareness, patient support, and transplant policy reform. Most mature global analog of the Alliance's model.
• PKD Foundation of Canada: Canadian chapter of the Polycystic Kidney Disease Foundation focused on PKD patient support and advocacy. Listed as an Alliance supporter; directly comparable Canadian kidney-patient nonprofit in the same donor ecosystem.

Broad incumbents

• Canadian Blood Services: National Canadian nonprofit managing blood, plasma, and transplant-related donor programs with system-wide health mandate. Comparable as a large established Canadian donor-system nonprofit; board member Lynn van der Linde previously worked there.
• Health Charities Coalition of Canada: Coalition of national health charities in Canada advocating for health research and policy. Comparable as an umbrella Canadian health nonprofit advocacy body, though broader in scope across disease areas.
• International Society of Nephrology: Global professional society for kidney care and research, advancing kidney health worldwide through research, education, and policy. Comparable in mission to advance kidney care standards, but operates at professional rather than patient level.

Emerging players

• Transplant Ambassador Program: Patient-led hospital-embedded peer support program for kidney patients and donors; Co-founded by the Alliance's President and explicitly partnered with the Alliance. Direct adjacent program with overlapping mission.
• Can-SOLVE CKD: Canada's national kidney research network funded by CIHR/SPOR supporting patient-oriented kidney research. Direct strategic partner of the Alliance with overlapping patient-partner and living-donor-transplant research focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/people/Kidney-Patient-Donor-Alliance-Canada/100091417179200
• LinkedInlinkedin.com/company/kidney-patient-donor-alliance-canada
• Instagraminstagram.com/kidney_alliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renal Patient and Donor Foundation